Policyholder Services



Will my OMIC policy cover me for using Restylane?

On December 12, 2003, Medicis received FDA approval to market Restylane in the United States. In recognition of the filler’s FDA approval status, OMIC will extend coverage to physicians who use Restylane for the correction of facial wrinkles and/or lip augmentation. OMIC also offers a sample Restylane consent form, developed by Dr. John Shore, a member of OMIC’s Underwriting and Risk Management Committees and practicing oculoplastic surgeon.

Click here for sample Consent for Restylane Injection form.

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment



Six reasons OMIC is the best choice for ophthalmologists in America.

#6. Supporting your specialty.

OMIC was founded by members of the American Academy of Ophthalmology nearly a quarter century ago and is the only carrier sponsored and endorsed by AAO. OMIC is also endorsed by 40 other ophthalmic societies. The OMIC partnerships with state and subspecialty societies qualifies their members for an exclusive 8% premium credit. Contact your state society for details.

61864684